Loading…
Loading…
Acumen Wealth Advisors LLC decreased its stake in shares of Elevance Health, Inc. (NYSE: ELV) by 51.5% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,935 shares of the company's stock after selling 7,357 shares during the quarter. Acumen Wealth Advisors
US equities advanced during Q2, supported by another quarter of better-than-expected corporate earnings and continued enthusiasm for companies benefiting from artificial intelligence-related investment. Our bottom five contributors to return in Q2 were Accenture, CME Group, Salesforce, Boston Scientific and EOG Resources. Our top five contributors to return in Q2 were Texas Instruments, Lam Research, NXP Semiconductors, Elevance Health and Alphabet.
The purchase of 1,000 shares at $366.05 per share represents a total capital commitment of $366,050. This transaction increased the director's total direct equity position by 10% relative to his pre-trade holdings.
Elevance Health (NYSE: ELV) raised its 2026 adjusted earnings outlook after second-quarter results came in ahead of management's expectations, citing favorable benefit expense performance, disciplined cost management and improving execution across several major business lines. President and CEO Gail Boudreaux said the company now expects 2026 adjusted diluted earnings per share of at least $27. Chief
The CEO executed an open-market purchase of 2,725 shares, representing a capital commitment of ~$1.0 million. The transaction increased the insider's total equity holdings by 2% of the previously held position.
Your Medicare Advantage plan stays active on paper, but the hospital you have used for decades can quietly vanish from your network before your next appointment, and the protections meant to help you come with conditions most patients never see coming.
Elevance Health Inc. (NYSE:ELV) on Wednesday reported upbeat second-quarter results and raised its full-year guidance.
Elevance Health, Inc. (ELV) Q2 2026 Earnings Call Transcript
Full call transcripts — prepared remarks + analyst Q&A — with speaker-by-speaker formatting and one-click switching across every quarter on file.
Click below to see what's inside, then upgrade to read every transcript for ELV and 80,000+ other tickers.
Transcripts source: company-published earnings calls. Speaker attribution and formatting are processed in-app.